I don’t believe that a brokerage is “supposed to”

New Post Public Reply Private Reply Replies (2) Message Board
Mo Mo #66884
1,389
I don’t believe that a brokerage is “supposed to” borrow shares from a cash account that has GTC sell orders on those particular shares. I also believe if you set up your account as a “margin account” then the brokerage firm has a green light to borrow your shares regardless of whether you have GTC’s established or not. The concept of setting up GTC’s in a cash account is to minimize the amount of shares that can be borrowed out to LEGAL SHORT SELLERS who as the term suggests legally borrow the shares against their position. The LEGAL short position on IPIX has always been relatively small in the 1M-3M share range. The danger of setting up GTC’s is for example if you set them at $2 thinking you can always move the price up. The problem is if IPIX gets halted on good news and you get locked out of moving up your GTC’s. If IPIX SP were to gap up to $5 your shares would be grabbed by the MM’s at $2 before you had an opportunity to increase or pull your GTC order. The point is that you should only set GTC’s at a price you are comfortable in parting with your shares regardless of how high SP runs.

The ILLEGAL Naked Short Selling (NSS) on IPIX accumulation IMO dwarfs the legal short number but the exact number is impossible to know with certainty as the criminals are obviously not publicly documenting their crimes. My guess is that number is 300M+ shares. The general public for example thinks the Fed just “prints” extra money when much of inflated dollars are simply electronic transactions. Illegal NSS is similar to this as it is an electronic IOU as shares are not covered by legally borrowing them. My 300M+ NSS share estimate is a guess but it is based on historical “volume” on IPIX and the obvious use of this fake volume, mirrored trades and the deployment of NSS to compress IPIX SP. For details on the published “volume” check out 4kids post #66880 or my summary of these numbers on post #66884. I was as usual overly optimistic on my projected timelines but the volume numbers and milestones are still valid. The volume over the past 3 years is telling going from 88M to 124M to 382M as the SP has been compressed the last 6 years from $3.66 - $4.93/$1.28/$1.16 - $0.73/$.053 - $.07/ to $.05/ to $.17 and now only .25 as IPIX enters a human trial that if successful will bring in millions of investor demand that the criminals will not be able to financially hold back as IPIX SP increases.

There have been questions of when/if the criminals have to cover their naked position. The answer IMO is that they will not cover until they are forced to and every single share needs to be accounted for or if a time specific event triggers them to cover. Remember that the criminals Plan A is to compress the hell out of their targeted companies until they cripple them and eventually force them out of business. If Plan A works they walk away with millions in profits and never have to cover their naked position. Survivors like IPIX present a problem to them especially if they have breakout success (Pandemic gold standard treatment) or get bought out by a bigger entity. Sufficient funding that eliminates the need to issue additional shares and freezes OS count is also very bad news for the criminals as it takes away their leverage to compress. The criminal’s enemy is the law of actual supply/demand.

IPIX has key milestones that if successful will bring in a huge increase in retail investors and as the SP increases there will be a point where institutional investments will take legitimate volume to even much greater levels. IPIX’s key milestones include successful human B-CV19 trial, Funding via either government grants or BP partnership, EUA, revenue commitments as the leading CV19 therapeutic, Up Listing and at some point a very major short squeeze as the criminal hedge fund and their minions are forced to cover the gigantic hole that they have illegally dug.

The recent epic rise on GME stock was a coordination of small retail investors that discovered a heavily shorted stock and decided if they bought in mass and held tightly that they could create an imbalance of supply demand and that the hedge fund would be forced to cover and caught with their pants down. Put options (which will be available on IPIX once we are Up Listed) may have contributed as the fuse (as they have a time element to them) in this blowup but they are not the key point. The WSB investors targeted GME specifically because of the high percentage of PUBLISHED short position which shows the legal Short Sale position. The strategy was to get a large retail community to buy stock in GME and other highly legally shorted companies, hold tight and not sell and force the Hedge Fund (HF) into a short squeeze due to a supply/ demand imbalance with these small investors sitting on a high percentage of float.

What is driving GME up to the stratosphere IMO is the HF got caught with their pants down and were forced to cover their illegal naked position. Think about this situation like a ship running into an iceberg sticking 5 feet above the water (The legal Short Position). The iceberg that is not visible goes hundreds of feet below the surface (illegal NSS) and is the real reason that the ship sunk. The WSB guys probably had a good hunch that there was a naked position on GME but I doubt they dreamed it would go this high or that the iceberg was so deep. GME's 52 week low is $2.57 and closed Friday at $325. The market halted trading several times the past few days and froze trader’s accounts to try to let the HF cover their naked position IMO.

I actually think this type of percentage increase could easily happen to IPIX in the future. If milestones of strong trial results, funding via large government grants or BP partnership , Emergency Use Authorization, and Up List off the OTX we could attract enough retail volume to mimic the GME squeeze. The similarity is the large HF naked position. The difference is IPIX being a new stock darling as a worldwide CV19 savior and attracting both Retail AND institutional demand vs a GME stock which is an outdated brick and mortar gaming version of a dead Blockbuster Video model. I personally believe a pandemic killing new drug will dwarf in comparison of investment demand but time will tell.

The clock now starts next week with the initiation of B-CV19 human trials.

Tick tock.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Paris Baguette Opens New Café in Novato, CA

Updated Category News Views 76

Another Feather in Paris Baguette’s Cap Alright, as far as pastry shops go, Paris Baguette is rolling out those cinnamon rolls like they're planting flags on the moon. They've just added a new café in Novato, California, bringing the artisanal charm of their iconic baked goods to yet another American doorstep. A Local Affair with Big Aspirations The man of the hour,...

Continue Reading
Will Hair Loss Drugs Challenge Transplant Clinics?

Updated Category News Views 73

Emerging Treatments Stir Up Hair Loss Scene You ever get the feeling we're on the brink of something big? That's where we are with hair loss treatments, folks. As of late 2026, new drugs are making waves in clinical trials, but they’re not yet giving hair transplant clinics any sleepless nights. Smile Hair Clinic's co-founders, Dr. Mehmet Erdo?an and Dr. Gökay Bilgin,...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 214

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 131

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 80

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
Navigating Roof Damage Insurance Claims: Key Insights

Updated Category News Views 135

No one wants to deal with roof damage, but knowing the rules of the game is half the battle. The landscape of insurance claims can be tricky—especially when Mother Nature starts playing hard ball. Here, we break down what homeowners need to know to stay one step ahead in these situations. Unpacking Roof Damage Coverage Most homeowners think they've got things covered...

Continue Reading
KeyCorp Plans Redemption of Series E Preferred Stock

Updated Category News Views 112

KeyCorp Drops a Major Redemption Bombshell Out of the blue, KeyCorp (NYSE: KEY) just tossed a curveball at investors with the announcement they’re redeeming every last one of their Series E Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock shares come December 15, 2026. This move is bound to stir the pot a bit even if you’ve been around the block a few...

Continue Reading
Honoring Boston's Architects Changing the Game

Updated Category News Views 75

Celebrating Architecture's Influencers in Boston Every now and then, a profession needs a wake-up call. Stirring the pot, shaking the roots, call it what you will, but when folks rally together with a shared vision, change doesn't just seem possible — it's inevitable. On November 12, the Boston Society of Architects (BSA) and Architecture in Common (AiC) did just that...

Continue Reading
SOCSA: The Future of Safety in Confined Spaces?

Updated Category News Views 100

Autonomous Tech Meets Safety Regulations Some days innovation hits like a ton of bricks, and here we go again—this time with a gizmo aiming to shake up the safety game in confined spaces. Enter the SOCSA, the Self Operating Confined Space Attendant, designed by a seasoned agriculture worker who's had a ringside seat to enough OSHA rule breaches to fill a book. But ain't...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 62

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading

Top 5 Most Recently Viewed Articles

Dr. Mark Adams Takes the Helm as NDX's New President

Updated Category News Views 698

Dr. Mark Adams Takes the Helm as NDX's New President National Dentex Labs (NDX), a well-regarded provider of dental prosthetics and laboratory solutions, recently announced the appointment of Dr. Mark Adams as their new President. This strategic move positions the company for significant growth and innovation in the dental industry. Dr. Adams: A Proven Leader in Dentistry...

Continue Reading
Firefly Metals Secures C$30 Million Financing for Growth

Updated Category News Views 243

Firefly Metals Ltd Partners with BMO for Financing Firefly Metals Ltd (ASX: FFM, TSX: FFM), a rising star in the copper and gold sector, recently disclosed an agreement with BMO Nesbitt Burns Inc. This partnership is poised to solidify the company’s financial standing by instituting a bought deal financing arrangement, which is expected to yield C$30 million...

Continue Reading
Bird Construction Reports Impressive Q3 Growth and Impactful Acquisitions

Updated Category News Views 153

Bird Construction Achieves Remarkable Q3 Financial Results Bird Construction Inc. has recently shared robust financial outcomes for the third quarter, underscoring its growth and profitability trajectory. During this period, Bird Construction built on its earlier successes from the first half of the year, demonstrating solid momentum as it seeks a commendable finish to...

Continue Reading
KeyBank Partners with Zentist to Enhance Dental Revenue Cycles

Updated Category News Views 88

Understanding the Partnership Between KeyBank and Zentist Recently, KeyCorp (NYSE: KEY) formed a strategic partnership with Zentist, a well-regarded software provider that focuses on Insurance Revenue Cycle Management (RCM) for Dental Support Organizations (DSOs). This collaboration includes a minority investment designed to improve the financial operations of dental...

Continue Reading
Market Trends Shifting as Procter & Gamble Takes Center Stage

Updated Category News Views 306

Procter & Gamble: Analyzing Market Whales' Moves Recent trading activity surrounding Procter & Gamble (NASDAQ: PG) has captured the attention of financial analysts and investors alike. A remarkable bullish trend has emerged, as major traders initiate 16 unusual options trades reflecting confidence in this enduring brand. Understanding the Trader Sentiment Our assessment...

Continue Reading